GBGB1720622.8A
GB201720622D0
(en)
|
2017-12-11 |
2017-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary
|
DK18819366.8T
DK3585383T3
(en)
|
2017-12-11 |
2018-12-11 |
USE OF 3- [5-AMINO-4- (3-CYANOBENZOYL) -PYRAZOL-1-YL] -N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE PREVENTION OF ACUTE EXTENSIONS OF CHRONIC OBSTRUCTIVE
|
EP21156673.2A
EP3845228A1
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
|
AU2018381874A
AU2018381874A1
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-(5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl)-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
|
JP2020531614A
JP7372680B2
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease.
|
DK18819365.0T
DK3585382T3
(en)
|
2017-12-11 |
2018-12-11 |
USE OF 3- [5-AMINO-4- (3-CYANOBENZOYL) -PYRAZOL-1-YL] -N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE TREATMENT OF ACUTE EXTENSIONS OF CHRONIC OBSTRUCTIVE LUNG
|
ES18819366T
ES2882978T3
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3- [5-amino-4- (3-cyanobenzoyl) -pyrazol-1-yl] -N-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
|
KR1020207019715A
KR20200097311A
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbation of chronic obstructive pulmonary disease
|
EP18819366.8A
EP3585383B1
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
|
PL18819366T
PL3585383T3
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
|
CA3085544A
CA3085544A1
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
|
HUE18819366A
HUE054266T2
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
|
PT188193650T
PT3585382T
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
|
US15/733,213
US11234967B2
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
|
PCT/GB2018/053591
WO2019116022A1
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
|
EP18819365.0A
EP3585382B1
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
|
PCT/GB2018/053590
WO2019116021A1
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
|
PT188193668T
PT3585383T
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
|
HUE18819365A
HUE055425T2
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
|
AU2018382895A
AU2018382895A1
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-(5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl)-N-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
|
PL18819365T
PL3585382T3
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
|
CA3085545A
CA3085545A1
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
|
KR1020207019714A
KR20200097310A
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbation of chronic obstructive pulmonary disease
|
US15/733,212
US11701341B2
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
|
ES18819365T
ES2884789T3
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3- [5-amino-4- (3-cyanobenzoyl) -pyrazol-1-yl] -N-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
|
JP2020531621A
JP7280627B2
(en)
|
2017-12-11 |
2018-12-11 |
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
|